Save £0.24
Nytol One-A-Night 50mg Tablets: Fast-Acting Sleep Aid
£8.19 Original price was: £8.19.£7.95Current price is: £7.95. Inc. tax
In stock
Add to wishlist Add to compare
SKU: C2C_48788
Categories: Anxiety, Stress, Nervousness, Sleep Aids, Temporary Insomnia
Tags: Nytol, sleep aid
Description
Nytol One-A-Night 50mg Tablets: Fast-Acting Sleep Aid
Nytol One-A-Night leverages the power of diphenhydramine hydrochloride, a well-known antihistamine, to induce drowsiness by inhibiting the arousal-promoting effects of histamine in the brain. By reducing alertness, it helps ease the transition into a restful sleep, promoting a deeper and more rejuvenating slumber.
- Fast-acting formula for quick relief from sleeplessness
- Clinically proven to promote better sleep quality
- Each tablet contains 50mg of diphenhydramine hydrochloride
- Ideal for individuals experiencing temporary difficulties in falling asleep
- Helps alleviate stress, jet lag, or medication-related sleep disturbances
- Suitable for adults and children over 16 years old
Usage Instructions:
Take one tablet approximately 20 minutes before bedtime with water. Do not exceed the recommended dosage of one tablet per night. For detailed dosage guidelines, refer to the enclosed leaflet.
Ingredients:
- Active Ingredient: Diphenhydramine Hydrochloride 50mg
- Other Ingredients: Anhydrous lactose, Microcrystalline cellulose, Maize starch, Stearic acid, Silicon dioxide
Warnings and Precautions:
- Avoid alcohol consumption while using Nytol One-A-Night as it may intensify drowsiness.
- Not suitable for individuals with allergies to diphenhydramine hydrochloride or related ingredients.
- Consult a healthcare professional before use if pregnant, breastfeeding, or taking other medications.
- Store in a cool, dry place below 25°C and keep out of reach of children.
- Do not use beyond the expiration date printed on the packaging.
Always read the product leaflet before use.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.